Caplin Point Laboratories Limited(IN:CAPLIPOINT)
₹2,520.95+19.90 (+0.80%)
IN:CAPLIPOINT
Caplin Point Laboratories Limited Revenue
₹2,520.95
At close:+19.90 (+0.80%)
Want to see IN:CAPLIPOINT full AI Analyst Report?
Caplin Point Laboratories Limited (CAPLIPOINT) Revenue
4 Followers
Caplin Point Laboratories Limited Revenue
Caplin Point Laboratories Limited had a revenue of 6.00B in the quarter ending Mar 31, 2026, with 10.57%. This bring the company's revenue in the last twelve months to 21.87B, Increased 4.57%. In the fiscal year ending Mar 31, 2026, Caplin Point Laboratories Limited had annual revenue of 21.87B with 12.77% growth.
- Revenue (ttm)
- 21.87B
- Revenue Growth
- 15.01%
- P/S Ratio
- 8.69
- Revenue/Employee
- INR 6,421,580
- Employees
- 3,406
- Market Cap
- INR 190.11B
Revenue Chart
Caplin Point Laboratories Limited Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 21.87B | 2.48B | 12.77% |
| Mar 31, 2025 | 19.40B | 2.43B | 14.35% |
| Mar 31, 2024 | 16.96B | 2.28B | 15.51% |
| Mar 31, 2023 | 14.68B | 1.97B | 15.53% |
| Mar 31, 2022 | 12.71B | 2.09B | 19.64% |
| Mar 31, 2021 | 10.62B | 1.98B | 22.96% |
| Mar 31, 2020 | 8.64B | 2.15B | 33.12% |
| Mar 31, 2019 | 6.49B | 1.09B | 20.21% |
| Mar 31, 2018 | 5.40B | 1.38B | 34.42% |
| Mar 31, 2017 | 4.02B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:CAPLIPOINT | 21.87B |
| IN:AKUMS | 20.26B |
| IN:GRANULES | 56.18B |
| IN:JUBLPHARMA | 86.08B |
| IN:PPLPHARMA | 97.79B |
| IN:STAR | 48.59B |